Skip to main content
Fig. 1 | Molecular Brain

Fig. 1

From: Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease

Fig. 1

The Wnt/β-catenin signaling pathway. a When Wnt proteins bind to LRP5/6 and FZD, the phosphorylation and degradation of β-catenin is blocked, resulting in stabilization, accumulation and nuclear translocation of β-catenin and subsequent activation of the pathway. b When Wnt binding to receptors is blocked by Wnt antagonist Dkk1, SOST and sFRP, β-catenin is phosphorylated by Ck1 and GSK3β, and subsequently degraded by the 26S proteasome. Wnt receptor Fzd and Wnt co-receptor LRP5/6 are positively regulated by Rspo proteins and their receptors LGR4, LGR5 and LGR6, and negatively regulated by E3 ubiquitin ligases RNF43 and ZNRF3 at the cell surface

Back to article page